Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: January 2008
-
By Donald Zuhn — As reported in today’s issue of the IPO Daily News (an e-mail and online newsletter distributed by the Intellectual Property Owners Association), a draft of the Senate Judiciary Committee’s report on the Patent Reform Act of 2007 (S. 1145) has begun to circulate on the internet. The 106-page draft…
-
By Kevin E. Noonan — In the run-up to the planned implementation of the Patent and Trademark Office’s misguided new rules limiting continuation applications and claims (enjoined on October 31st by Judge Cacheris sitting in the Eastern District of Virginia), the Office made very clear its intention to strictly enforce the rules once…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Eli Lilly and Company v. Mayne Pharma Limited et al.1:08-cv-00037; filed January 10, 2008 in the Southern District of Indiana Infringement of…
-
By Kevin E. Noonan — In 2004, Purdue Pharma L.P. and its related companies were found to have obtained patents (U.S. Patent Nos. 5,656,295; 5,508,042; and 5,549,912) for their OxyContin® opioid pain relief formulations through inequitable conduct. The basis for this determination was that Purdue had maintained before the Patent Office that its…
-
January 14-15, 2008 – Patent Law Institute (Practising Law Institute) – New York, NY January 25-26, 2008 – Buying, Selling and Licensing Patents: New Case Law, Rules, Legislation and Markets (Law Seminars International) – San Francisco, CA January 28-29, 2008 – Patent Law Institute (Practising Law Institute) – San Francisco, CA January 30-February 1, 2008…
-
The American Bar Association (ABA) section of Intellectual Property Law will be holding the 23rd Annual Intellectual Property Law Conference on April 10-12, 2008 in Arlington, Virginia. Among the topics that will be covered at the conference are: Are the Supreme Court and Federal Circuit on the Same Page For Patent Law? 2021: A Patent…
-
By Kwame Mensah — PuriCore recently announced that it had been granted U.S. Patent No. 7,276,255, entitled "Wound and Ulcer Treatment with Super-Oxidized Water." The ‘255 patent covers methods of treating an open wound with hypochlorous acid solutions at neutral or near-neutral pH. The method includes two processes: reducing wound bioburden and promoting…
-
By Christopher P. Singer — In a January 7, 2008 news release, Seattle Genetics, Inc. announced that it will receive a $4 million milestone payment from its collaboration with Genentech, Inc. This payment arose as a result of Genentech’s initiation of a phase Ib clinical trial of SGN-40 in combination with Rituxan® (rituximab)…
-
By Jason Derry — Celltrion, Inc. and CSL Limited have announced an agreement to develop and commercialize a monoclonal antibody for treating acute myeloid leukemia (AML). The antibody, designated CSL 360, is currently in Phase 1 clinical trials in Australia. CSL is a global, biopharmaceutical company located in Australia, having facilities throughout the…
-
By Donald Zuhn — Proteologics, Inc. announced today that it has been granted U.S. Patent No. 7,268,227. The ‘227 patent is the second U.S. patent to be awarded to the Rehovot, Israel-based biopharmaceutical company. According to the statement released by Proteologics, the ‘227 patent encompasses siRNA molecules that inhibit the expression of the…
Patent Docs 